School of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain; School of Health and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
School of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain; Department of Angiology and Vascular Surgery, Hospital del Mar, Barcelona, Spain; Cardiovascular Epidemiology and Genetics Group, REGICOR, IMIM (Instituto Hospital del Mar de Investigaciones Médicas), Barcelona, Spain; Center for the Biomedical Research Network in Cardiovascular Diseases (CIBERCV), Barcelona, Spain.
Prev Med. 2019 Jul;124:17-22. doi: 10.1016/j.ypmed.2019.04.022. Epub 2019 May 2.
Early smoking onset age (SOA) is a public health concern with scant empirical evidence of its role in health outcomes. The study had two aims: i) to assess whether an early SOA was associated with the risk of fatal and non-fatal CVD and all-cause and CVD mortality and ii) to explore the linear and non-linear association between SOA and the outcomes of interest. Data from 4499 current or former smokers, recruited from 1995 to 2005, aged 25 to 79 years, and with a median 7.02 years of follow-up, were obtained from the REGICOR population-based cohort. In the present analysis, performed in 2018, the independent variable was SOA and the dependent variables were CVD events, CVD mortality, and all-cause mortality. Penalized smoothing spline methods were used to assess the linear and non-linear association. During follow-up, 361 deaths and 210 CVD events were recorded. A significant non-linear component was identified in the association between SOA and CVD outcomes with a cut-off point at 12 years: In the group aged ≤12 years, each year of delay in SOA was inversely associated with CVD risk (HR = 0.71; 95%CI = 0.53-0.96) and CVD mortality (HR = 0.58; 95%CI = 0.37-0.90). No association was observed in the older SOA group. A linear association was observed between SOA and all-cause mortality, and each year of delay was associated with 4% lower risk of mortality (HR = 0.96; 95%CI = 0.93-0.98). The associations were adjusted for lifelong exposure to tobacco and cardiovascular risk factors. These results reinforce the value of preventing tobacco use among teenagers and adolescents.
早期吸烟起始年龄(SOA)是一个公共卫生关注点,但关于其对健康结果的影响的实证证据很少。该研究有两个目的:i)评估早期 SOA 是否与致命和非致命心血管疾病(CVD)以及全因和 CVD 死亡率的风险相关;ii)探讨 SOA 与感兴趣的结局之间的线性和非线性关系。这项分析于 2018 年进行,从 REGICOR 基于人群的队列中获取了 1995 年至 2005 年期间招募的 4499 名当前或前吸烟者的数据,这些吸烟者年龄在 25 至 79 岁之间,中位随访时间为 7.02 年。在本分析中,独立变量是 SOA,因变量是 CVD 事件、CVD 死亡率和全因死亡率。惩罚平滑样条方法用于评估线性和非线性关系。在随访期间,记录了 361 例死亡和 210 例 CVD 事件。SOA 与 CVD 结局之间的关联存在显著的非线性成分,其切点为 12 年:在年龄≤12 年的组中,SOA 每延迟一年与 CVD 风险呈负相关(HR=0.71;95%CI=0.53-0.96)和 CVD 死亡率(HR=0.58;95%CI=0.37-0.90)。在年龄较大的 SOA 组中未观察到相关性。SOA 与全因死亡率之间存在线性关联,每延迟一年与死亡率降低 4%相关(HR=0.96;95%CI=0.93-0.98)。这些关联在调整终生暴露于烟草和心血管危险因素后仍然存在。这些结果强化了预防青少年吸烟的重要性。